Skip to main content

Table 4 Estimated odds ratio for achieving guideline-recommended laboratory test targets: CDSS vs Controls

From: Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study

Test

Group

N

N (%) in compliance

OR (CI)a

p-value

PTH

CDSS

12835

4918 (38)

0.99 (0.93, 1.06)

0.851

Control

23582

9062 (38)

25-D

CDSS

16910

9332 (55)

1.18 (1.12, 1.25)

<0.001

Control

32903

17362 (53)

Calcium

CDSS

67222

59847 (89)

1.05 (0.99, 1.10)

0.113

Control

167026

148877 (89)

Phosphorus

CDSS

17764

15456 (87)

1.08 (0.99, 1.06)

0.069

Control

29011

24605 (85)

CO2

CDSS

167237

120910 (72)

0.99 (0.96, 1.03)

0.657

Control

68208

47701 (70)

Hemoglobin

CDSS

47740

18528 (39)

0.92 (0.88, 0.97)

0.001

Control

45229

108476 (42)

TSAT

CDSS

8119

5495 (68)

0.98 (0.90, 1.07)

0.699

Control

15717

10716 (68)

LDL-C

CDSS

25278

17232 (68)

1.16 (1.10, 1.22)

<0.001

Control

63738

41957 (66)

Urine panel

CDSS

8806

4263 (48)

0.94 (0.87, 1.02)

0.156

Control

25814

12877 (50)

  1. aValues are estimated odds ratios for meeting guideline target values of CKD relevant laboratory measurements after adjustment for age at entry into the cohort, gender, CKD stage, and physician specialty